Glenmark To Debut Ryaltris In Australia
Rhinitis Therapy Gets TGA Nod For Launch In 2020
Glenmark ended 2019 on a buoyant note, with its rhinitis therapy getting the go-ahead in Australia. Though not seen as a huge commercial opportunity in the island continent, the clearance augurs well for the product’s overall trajectory.
